Spain-based CDMO, mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, has appointed Jurgen Van Broeck as CEO. Van Broeck, who has served as global commercial director since June 2023,…
Spain: Van Broeck appointed as CEO of mAbxience
…
…






